Schäfer, Martin

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Strangfeld, A., Schäfer, M., Gianfrancesco, M. A., Lawson-Tovey, S., Liew, J. W., Ljung, L., Mateus, E. F., Richez, C., Santos, M. J., Schmajuk, G., et al. (2021) · Annals of the Rheumatic Diseases

COVID-19 Clinical Research StudiesRheumatoid Arthritis Research and Therapies

Cited by 667

Anatomy of the CNS opioid systems

Khachaturian, H., Lewis, M. E., Schäfer, M. K.-H., & Watson, S. J. (1985) · Trends in Neurosciences

Neuropeptides and Animal PhysiologyPain Mechanisms and Treatments

Cited by 428

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Sparks, J. A., Wallace, Z. S., Seet, A. M., Gianfrancesco, M. A., Izadi, Z., Hyrich, K. L., Strangfeld, A., Gossec, L., Carmona, L., Mateus, E. F., et al. (2021) · Annals of the Rheumatic Diseases

Rheumatoid Arthritis Research and TherapiesCOVID-19 Clinical Research Studies

Cited by 238

Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases

Hasseli, R., Mueller-Ladner, U., Hoyer, B. F., Krause, A., Lorenz, H.-M., Pfeil, A., Richter, J., Schäfer, M., Schmeiser, T., Strangfeld, A., et al. (2021) · RMD Open

COVID-19 Clinical Research StudiesRheumatoid Arthritis Research and Therapies

Cited by 117

The thyrotropin-releasing hormone-degrading ectoenzyme: the third element of the thyrotropin-releasing hormone-signaling system

HEUER, H., SCHÄFER, M. K.-H., & BAUER, K. (1998) · Thyroid

Neuropeptides and Animal PhysiologyThyroid Disorders and Treatments

Cited by 39